期刊文献+

布南色林口腔崩解片制备工艺的研究

Preparation Technology of Blonanserin Orally Disintegrating Tablets
下载PDF
导出
摘要 目的:采用正交试验筛选布南色林口崩片的处方,并测定其溶出度。方法:以内崩解剂微晶纤维素的用量、填充剂乳糖的用量、外崩解剂交联羧甲基淀粉钠的用量为考查因素,以口崩片的崩解时间(td)、润湿时间(t)和混悬稳定性(△A)为评价指标进行正交试验,确定最佳处方;对优化处方所制样品测定其溶出度。结果:优选工艺为微晶纤维素30%、乳糖15%、交联羧甲基淀粉钠10%,所制样品平均td为19.8s,t为20.1s,△A为0.0016;30s内药物基本溶出完全。结论:所选处方制备的样品符合《中国药典》相关规定。 Objective: To optimize the formulation of blonanserin orally disintegrating tablets by orthogonal experiment and to determine its dissolution. Methods: The formulation of tablets was optimized by orthogonal experiment based on three factors: the proportions of microcrystalline cellulose, lactose, and the cross-linksodium starch glycolate and 3 indexes: disintegrating time (td), the wet time(t) and the suspend stability(△ A).The dissolution of the tablets was determined by HPLC. Results: To optimum preparation technical conditions for the tablets were as follows:the proportions of mierocrystalline cellulose, lactose, and the cross-linksodium starch glycolate were30%,15% and 10% respectively. The tablets disintegrated completely within30s, with meantdat 19.8s, t 20.1s, and △ A 0.0016. Conclusions: The blonanserin orally disintegrating tablets were up to the standards of Chinese Pharmacopeia.
作者 吴彪 李海英
出处 《中国中医药咨讯》 2010年第14期264-265,共2页
关键词 制备工艺 口腔崩解片 羧甲基淀粉钠 微晶纤维素 样品测定 《中国药典》 正交试验 最佳处方 blonanserin Orally disintegrating tablets Orthogonal experiment
  • 相关文献

参考文献3

二级参考文献11

  • 1吴晓明.盐酸坦洛新口腔崩解片在日本获得上市许可[J].上海医药,2004,25(12):558-558. 被引量:1
  • 2Oka M, Noda Y, Ochi Y, et al. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties [J]. J PharmacolExp Ther, 1993, 264(1) : 158-176. 被引量:1
  • 3Oka M, Hino K. AD-5423 [J]. Drugs Future, 1992, 17(1): 9-11. 被引量:1
  • 4Katsuhiko H, Naoki K, Masato S, et al. 2-(1-Piperazinyl)- 4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same: EP, 385237 [P]. 1990-09-05. (CA 1990, 114: 143438) 被引量:1
  • 5Alonso-alij C, Michels M, Schirok H, et al. Monocyclic aroylpyridinones as antiinflammatory agents: WO, 200376405 [P]. 2003-09-18. (CA 2003, 139: 261170) 被引量:1
  • 6Hauser CR, Eby CJ. Cyclization of β-ketonitriles or β-ketoamides with ketones by polyphosphoric acid to form substituted 2-pyfidones [J]. J Am Chem Soc, 1957, 79 (3) : 728-731. 被引量:1
  • 7方积乾.医药数理统计方法[M].第3版.北京:人民卫生出版社,1999:170-180. 被引量:2
  • 8Dominique L. S. Ceulemans,Yves G. Gelders,Marie-Lise J. A. Hoppenbrouwers,André J. M. Reyntjens,Paul A. J. Janssen. Effect of serotonin antagonism in schizophrenia: A pilot study with setoperone[J] 1985,Psychopharmacology(3):329~332 被引量:1
  • 9王晓洁,朱忠华.抗精神分裂症药布南色林的合成[J].科教文汇,2007(12Z):219-219. 被引量:12
  • 10刘丽鹤,王鹏,李好枝.盐酸坦洛新血药浓度测定方法及其药动学研究进展[J].中国药学杂志,2003,38(7):488-490. 被引量:16

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部